CUNSA
Turning Supplement Ideas into Shelf-Ready Brands

Francisco Cáceres, CEO and Partner

Retailers, pharmacy chains and distributors building a food supplement category often face execution problems across the same project. Formulation, manufacturing, labeling and registration may sit with separate vendors, while quality control and post-launch support remain disconnected. These hand-offs can cause delays, regulatory uncertainty and higher costs.

CUNSA was built to remove that friction. Its 360-degree solution brings formulation, regulatory adaptation, packaging, manufacturing, quality documentation and commercial support into one accountable relationship, while customers retain control of the brand and commercial strategy.

“We start with the business, not the formula,” says Francisco Cáceres, CEO and partner.

Before recommending a product, CUNSA examines the end consumer, sales channel, target price points, competitive set and destination-country requirements. It also reviews existing products for gaps and overlaps, distinguishing traffic generators from margin contributors. CUNSA then balances entry products that attract new consumers with a core range designed to sustain sales volume. Differentiated offerings can then increase the value of the portfolio, giving retailers a planned launch sequence rather than a collection of unrelated products.

CUNSA’s retail and pharmacy perspective guides planning. Its recommendations account for shelf rotation, pricing tiers and category buyers’ needs, linking formulation choices to expected commercial performance.

Compliance and Quality by Design

CUNSA formulates around the destination market’s rules from day one. It defines the intended consumer benefit and dosage needed to deliver it credibly. Ingredients, dosages and claims are checked against local requirements, with compliant alternatives preserving the benefit when an ingredient or level is not permitted.

Format follows function. Capsules, softgels, powders and sachets affect dose, stability, cost per serving and consumer experience. Cost is managed through ingredient and format choices, not by reducing the active dose below the label promise.

Manufacturing takes place in the U.S. under FDA Current Good Manufacturing Practices in 21 CFR Part 111. Quality is verified through defined specifications, raw-material-to-finished-unit traceability and stability programs following ICH guidelines to support labeled shelf life.

That rigor builds regulatory confidence. Certificates of Analysis and Certificates of Free Sale support registration and import across markets, reducing trial and error during expansion. CUNSA exports to over 11 countries across the Americas, Asia, the Middle East and Africa, building experience in regulatory adaptation. Quality control remains independent of production, with separate personnel approving batches to ensure objective verification and credible documentation.

A Central American customer illustrates the model. The group wanted one competitive product for eight countries with different registration, labeling and claims requirements. CUNSA developed a compatible formula, adapted labels country by country while maintaining a consistent regional brand image, manufactured in its U.S. facility and prepared Certificates of Analysis and Certificates of Free Sale for health-authority processes.

The product cleared regulatory processes across all eight countries and is now on the market, with CUNSA supporting the customer’s expansion into additional markets.

Taking Products beyond the First Shelf

For CUNSA, launch is the beginning of the relationship. It reviews portfolio performance, closes gaps through its formulation team and develops technical and benefit sheets, point-of-sale materials and social media and e-commerce content grounded in formula benefits and local regulation. Sales teams, pharmacists and store staff learn what each product is, who it serves and how to communicate it correctly.

Consistent batch quality, documentation for every shipment and post-sale support sustain growing volumes. Customers can use proven white-label formulas for faster entry, develop exclusive private-label products for differentiation or distribute CUNSA brands like Sunvit Life and Sportlab without changing manufacturers.

CUNSA has expanded its manufacturing footprint with a new facility in Miami-Dade County. It is also strengthening its quality and international sales teams while investing in digital systems intended to improve customer visibility and responsiveness.

CUNSA aims to be the bridge between U.S. manufacturing standards and global markets seeking compliant, well-documented supplement products, with quality demonstrated batch after batch and partnerships built around category growth. Its recognition as the Top Healthy Nutritional Food Supplements 2026 reflects that end-to-end approach.